Skip to main content
Watch Insiders
SGMTHealthcare

Sagimet Biosciences Inc (SGMT) Insider Trading

In the last 90 days, 1 Sagimet Biosciences Inc (SGMT) insider reported no open-market purchases and 2 sales totaling $3,792,726. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Aug 14, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Aug 14, 2026George KembleDirectorSale350,987$10.23$3,591,580
Aug 11, 2026George KembleDirectorSale20,206$9.95$201,147
Jul 20, 2026David HappelPresident & CEOSale64,051$7.76$497,068
Jul 20, 2026Elizabeth RozekChief Legal & Admin. OfficerSale10,545$7.76$81,832
Jul 20, 2026George KembleDirectorSale18,844$7.46$140,529

Common questions

SGMT insider trading FAQ

Are SGMT insiders buying or selling?
Over the last 90 days, SGMT insiders were net sellers, reporting $0.00 of open-market purchases and $3,792,726 of sales.
When was the last SGMT insider purchase?
No open-market insider purchase of Sagimet Biosciences Inc stock was reported in the last 90 days.
Where does SGMT insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Sagimet Biosciences Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.